The Placebo Journal Blog points out that government programs that enlist others to root out physician wrongdoing promise monetary rewards and bounties, whereas a new program that enlists physicians to root out drug company wrongdoing promises to pay whistleblowers… well, you’ll see.

What would “Around the Mediverse” be without a tale of ridiculous litigation? The propofol litigation, however, could have real adverse consequences for those patients needing anesthesia now that one of its manufacturers has withdrawn from the US market. See Great Zs, Overlawyered, and Skeptical OB for details.

Dr. Wes discusses some of the often-overlooked biases inherent to the way medical research is conducted, and what it might mean for the wide applicability of results.

MLRs, what are they good for? David Williams and Reason have interesting, unorthodox takes on the question.

Rounding out this week’s selection, Dr. Rich has an unorthodox take on a hot-button issue… this one being the appropriate nature of the relationship between physicians and pharmaceutical companies. It’s a perspective that I haven’t seen well-elucidated elsewhere, so it’s well worth reading the full thing.